Recent studies demonstrate that overexpression of SPARC led to a significant decline in microvessel density, resulting in delayed tumour formation and reduction in tumour size in hepatocellular carcinoma xenografts (Lau et al, 2006). The gene discussed is SPARC; the disease is neoplasm.